WebAbout Us Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for ... WebApr 14, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for bacterial infections, including multi-drug resistant bacterial infections and rare diseases.
Did you know?
WebSpero Therapeutics is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for bacterial infections, … Web1 day ago · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and …
WebSep 22, 2024 · Spero Therapeutics, Inc. September 22, 2024, 2:00 AM · 8 min read The exclusive license allows GSK to commercialize tebipenem HBr in all territories, except Japan and certain other Asian... WebSpero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial
WebApr 10, 2024 · Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant, or MDR, bacterial... WebApr 6, 2024 · April 5, 2024, 9:59 PM · 13 min read. Spero Therapeutics, Inc. (NASDAQ: SPRO) Q4 2024 Earnings Call Transcript March 30, 2024. Operator: Good afternoon, and welcome to Spero Therapeutics Fourth ...
WebOct 28, 2024 · CAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and...
WebIf you have a question, comment, concern, or need assistance with your Sphero robot or littleBits kit, please fill out the form below, and a Sphero Customer Advocate will get in … things to do in memphis in octoberWebProducts Sphero 1.0 and 2.0. The original Sphero was initially prototyped by its inventors, Ian Bernstein and Adam Wilson, with a 3D-printed shell and electronics taken from a smartphone. It was then demonstrated at CES in … things to do in memphis kid friendlyWebspero therapeutics, inc. STOCK OPTION AGREEMENT—INCORPORATED TERMS AND CONDITIONS AGREEMENT made as of the date of grant set forth in the Stock Option Grant Notice by and between Spero Therapeutics, Inc. (the “Company”), a Delaware corporation, and the individual whose name appears on the Stock Option Grant Notice (the “Participant”). things to do in memphis in julyWebMar 30, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and … things to do in memphis in march 2023WebMay 3, 2024 · Shares of Spero Therapeutics Inc. SPRO, plummeted 68.4% toward a record low in premarket trading Tuesday, after the Massachusetts-based biopharmaceutical company said it is cutting 75% of its ... things to do in memphis tennessee in decemberWebView the latest Spero Therapeutics Inc. (SPRO) stock price, news, historical charts, analyst ratings and financial information from WSJ. SPRO Spero Therapeutics Inc. Stock Price & … things to do in memphis on saturdayWebMar 30, 2024 · Spero Therapeutics, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $47.44 million for the quarter ended December 2024, surpassing the Zacks... things to do in memphis tennessee in may